Evidence map›Paper›PMID 22403230›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Use and evaluation of molecular diagnostics for pneumonia etiology studies.

Niranjan Bhat, Katherine L O'Brien, Ruth A Karron, Amanda J Driscoll, David R Murdoch, Pneumonia Methods Working Group

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Standardization of Laboratory Methods for the PERCH Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  10. Article
  11. Review
  12. Diagnosis of Pulmonary Tuberculosis in Children: Assessment of the 2012 National Institutes of Health Expert Consensus Criteria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Article
  13. Article
  14. A review of the role ofPneumonia (Nathan Qld.) · 2015
    Review
  15. Article
  16. Article
  17. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2013
    Article
  18. What is the role of newer molecular tests in the management of CAP?Infectious disease clinics of North America · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Niranjan BhatDepartment of International Health, Johns Hopkins Bloomberg School of Public Health.
Katherine L O'Brien
Ruth A Karron
Amanda J Driscoll
David R Murdoch
Pneumonia Methods Working Group
Canterbury Health Laboratories · NZJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Institute for Clinical and Translational Research (KL2)KL2RR025006 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$12.9M
NCRR NIH HHS 1KL2RR025006-01NCRR NIH HHS KL2 RR025006Wellcome Trust 092654
6 · The paper itself

Abstract

Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These efforts allowed us to articulate the unique requirements of PERCH, establish that molecular methods would be central to our testing strategy, and focus on a short list of candidate platforms. This process also highlighted critical challenges in the general design and interpretation of diagnostic evaluation studies, particularly in the field of respiratory infections. Although our final molecular diagnostic platform was ultimately selected on the basis of operational and strategic considerations determined by the specific context of PERCH, our review highlighted several conceptual and practical challenges in respiratory diagnostics that have broader relevance for the performance and interpretation of pneumonia research studies.

Indexed as

BacteriaBacterial InfectionsHumansMicrobiological TechniquesMolecular Diagnostic TechniquesPneumoniaQuality ControlRespiratory Tract InfectionsSensitivity and SpecificitySpecimen HandlingTime FactorsVirus DiseasesViruses

Identifiers

PMID22403230
PMCPMC3297547
OpenAlexW2166105893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.